What is the Tirzepatide 60mg Dual Agonist Weight Loss Pen?

It is a once-weekly pre-filled injectable pen that combines GLP-1 and GIP receptor activity to support weight loss, appetite control, and improved blood sugar balance.

How does Tirzepatide work?

Tirzepatide mimics two incretin hormones. GLP-1 reduces appetite, slows digestion, and regulates post-meal glucose. GIP improves insulin sensitivity and fat metabolism. Together, they enhance weight loss and metabolic health.

What is the suggested dosage schedule?

Typical titration is once weekly: Weeks 1–4: 2.5mg; Weeks 5–8: 5mg; Weeks 9–12: 7.5mg; Weeks 13–16: 10mg; from Week 17 onwards: 12.5mg. Stay at the lowest dose that controls appetite effectively as advised by a healthcare professional.

Who should not use Tirzepatide?

It is not suitable for individuals who are pregnant, breastfeeding, or have contraindicated medical conditions. Always use under professional guidance.

Is Tirzepatide fully approved?

Tirzepatide is still under clinical investigation for obesity and type 2 diabetes. It is an investigational compound and should only be used with professional supervision.

What are the key benefits of this product?

It helps promote sustainable fat loss, reduce cravings, regulate blood sugar, and improve insulin sensitivity-all in a convenient once-weekly pre-filled pen.

How long does delivery take in South Africa?

Delivery usually takes 5–6 working days nationwide unless otherwise communicated.

Is this medical advice?

No. The information provided is for educational purposes only. Tirzepatide should only be used under the guidance of a qualified healthcare professional.

What is Tirzepatide 60mg Dual Agonist Weight Loss Pen?

The Tirzepatide 60mg pen is a once-weekly pre-filled injectable containing tirzepatide, a dual GLP-1 and GIP incretin therapy designed to support weight loss, appetite control, type 2 diabetes management, and metabolic health.

How should I follow the dosage schedule for the pen?

The pen features a dosage selector for gradual escalation: Week 1–4: 2.5 mg; Week 5–8: 5 mg; Week 9–12: 7.5 mg; Week 13–16: 10 mg; from Week 17 onwards: 12.5 mg — remain at the lowest effective dose as advised by a healthcare professional.

Is Tirzepatide 60mg a fully approved therapy?

No — the product is described as an investigational compound and is not yet a fully approved therapy; it should be used only under professional guidance.

What are the delivery and return policies in South Africa?

Nationwide shipping is available within 5–6 working days, and due to the sensitive medical nature of the product, returns and exchanges cannot be accepted.

Who should avoid using Tirzepatide 60mg?

It is not suitable for individuals who are pregnant or breastfeeding or those with contraindicated medical conditions; use only under the supervision of a healthcare professional.

Tirzepatide 60 packaging with injection pen on a white background

Tirzepatide 60mg Dual Agonist Weight Loss Pen – South Africa

Regular price ~~R 3,999.99~~ R 3,699.00 ZAR 8% OFF

ONLY 130 LEFT

Product Details

Tirzepatide 60mg Dual Agonist Weight Loss Pen – South Africa

Tirzepatide 60mg Pre-Filled Injectable Pen is a next-generation dual incretin therapy developed to support weight loss, appetite control, type 2 diabetes management, and improved metabolic health. With its unique combination of GLP-1 (Glucagon-Like Peptide-1) and GIP (Gastric Inhibitory Polypeptide) receptor activity, Tirzepatide delivers powerful results in a convenient once-weekly injectable pen.

How Tirzepatide Works

Tirzepatide mimics the actions of two important metabolic hormones:

GLP-1: reduces appetite, slows digestion, regulates post-meal blood sugar, and supports weight control.
GIP: improves insulin sensitivity, helps regulate fat metabolism, and reduces fat accumulation.

Together, these actions promote effective weight loss, lower calorie intake, and improved blood sugar balance, making Tirzepatide one of the most advanced investigational treatments available.

Key Benefits

Promotes sustainable fat loss and weight management
Helps control appetite and reduce cravings
Supports blood sugar regulation and insulin sensitivity
Once-weekly pre-filled injectable pen for ease of use
Backed by Body Pharm quality for reliable results

Suggested Dosage Schedule

The pen includes a dosage selector for gradual dose escalation:

Week 1–4: 2.5 mg
Week 5–8: 5 mg
Week 9–12: 7.5 mg
Week 13–16: 10 mg
From Week 17 onwards: 12.5 mg

Remain at the lowest dose that effectively controls appetite and supports continued results, as recommended by a healthcare professional.

BP Body Pharm Tirzepatide 60 pre-filled injectable pen packaging on an orange background

Important Safety Notes

Tirzepatide is currently undergoing clinical investigation for obesity management, type 2 diabetes, and metabolic health. It is not yet a fully approved therapy. Use only under professional guidance. Not suitable for individuals who are pregnant, breastfeeding, or with contraindicated medical conditions.

Delivery & Returns

Nationwide shipping across South Africa within 5–6 working days unless otherwise communicated. Due to the sensitive and medical nature of this product, returns and exchanges cannot be accepted.

Why Choose Tirzepatide 60mg?

The Tirzepatide 60mg Dual Agonist Weight Loss Pen is one of the most advanced investigational solutions for effective weight control and improved metabolic function. With precision dosing and once-weekly convenience, this pen offers South Africans a reliable option to support appetite control, fat reduction, and balanced glucose management.

Disclaimer: Tirzepatide is an investigational compound intended for supervised use only. This product is not intended to diagnose, treat, cure, or prevent any disease.

people are currently looking at this product

Back to Fat Burners South Africa